Baakman AC, Gavan C, van Doeselaar L, de Kam M, Broekhuizen K, Bajenaru O, Camps L, Swart EL, Kalisvaart K, Schoonenboom N, Lemstra E, Scheltens P, Cohen A, van Gerven J, Groeneveld GJ (2021) <br />Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's Disease<br /><i>British Journal of Clinical Pharmacology</i> <br /><br />Baakman AC, Alvarez-Jimenez R, Loewen G, de Kam ML, Broekhuizen K, Hilt DC, Groeneveld GJ (2019) <br />No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model<br /><i>Alzheimers Dement (N Y)</i> <b>5</b>: 89<br /><br />Baakman AC, t Hart E, Kay DG, Stevens J, Klaassen ES, Maelicke A, Groeneveld GJ (2016) <br />First in human study with a prodrug of galantamine: Improved benefit-risk ratio?<br /><i>Alzheimers Dement (N Y)</i> <b>2</b>: 13<br /><br />